Top-Rated StocksTop-RatedNASDAQ:PRVA Privia Health Group (PRVA) Stock Forecast, Price & News $24.48 +0.04 (+0.16%) (As of 05/26/2023 ET) Add Compare Share Share Today's Range$24.23▼$24.5750-Day Range$24.44▼$29.9352-Week Range$20.64▼$44.64Volume544,724 shsAverage Volume2.33 million shsMarket Capitalization$2.83 billionP/E Ratio222.55Dividend YieldN/APrice Target$39.19 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Privia Health Group MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside60.1% Upside$39.19 Price TargetShort InterestBearish5.43% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.68Based on 7 Articles This WeekInsider TradingSelling Shares$551.84 M Sold Last QuarterProj. Earnings Growth39.13%From $0.23 to $0.32 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.51 out of 5 starsMedical Sector152nd out of 1,012 stocksHealth Services Industry2nd out of 12 stocks 3.5 Analyst's Opinion Consensus RatingPrivia Health Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 13 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $39.19, Privia Health Group has a forecasted upside of 60.1% from its current price of $24.48.Amount of Analyst CoveragePrivia Health Group has only been the subject of 3 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted5.43% of the float of Privia Health Group has been sold short.Short Interest Ratio / Days to CoverPrivia Health Group has a short interest ratio ("days to cover") of 4.9.Change versus previous monthShort interest in Privia Health Group has recently increased by 189.90%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldPrivia Health Group does not currently pay a dividend.Dividend GrowthPrivia Health Group does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for PRVA. Previous Next 3.2 News and Social Media Coverage News SentimentPrivia Health Group has a news sentiment score of 0.68. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Privia Health Group this week, compared to 4 articles on an average week.Search Interest1 people have searched for PRVA on MarketBeat in the last 30 days. MarketBeat Follows6 people have added Privia Health Group to their MarketBeat watchlist in the last 30 days. This is an increase of 20% compared to the previous 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Privia Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $551,840,171.00 in company stock.Percentage Held by Insiders57.60% of the stock of Privia Health Group is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions66.83% of the stock of Privia Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Privia Health Group are expected to grow by 39.13% in the coming year, from $0.23 to $0.32 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Privia Health Group is 222.55, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 132.74.Price to Earnings Ratio vs. SectorThe P/E ratio of Privia Health Group is 222.55, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 132.87.Price to Earnings Growth RatioPrivia Health Group has a PEG Ratio of 3.03. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioPrivia Health Group has a P/B Ratio of 5.09. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Privia Health Group (NASDAQ:PRVA) StockPrivia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. was a former subsidiary of Brighton Health Group Holdings, LLC.Read More Receive PRVA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Privia Health Group and its competitors with MarketBeat's FREE daily newsletter. Email Address PRVA Stock News HeadlinesMay 27, 2023 | americanbankingnews.comPrivia Health Group (NASDAQ:PRVA) Stock Price Down 7.5%May 22, 2023 | americanbankingnews.comPrivia Health Group, Inc. (NASDAQ:PRVA) Receives $39.19 Average Target Price from AnalystsMay 28, 2023 | Stocks To Trade (Ad)15 A.I. Trading Opportunities a DayUsing our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.May 17, 2023 | americanbankingnews.comPrivia Health Group, Inc. (NASDAQ:PRVA) Director William M. Sullivan Sells 18,153 SharesMay 16, 2023 | americanbankingnews.comWilliam Blair Comments on Privia Health Group, Inc.'s Q2 2023 Earnings (NASDAQ:PRVA)May 14, 2023 | finance.yahoo.comWith 9.8% one-year returns, institutional owners may ignore Privia Health Group, Inc.'s (NASDAQ:PRVA) 9.2% stock price declineMay 13, 2023 | americanbankingnews.comWilliam M. Sullivan Sells 6,545 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) StockMay 11, 2023 | benzinga.comPrivia Health Gr 10% Owner Sold $536.47M In Company StockMay 28, 2023 | Stocks To Trade (Ad)15 A.I. Trading Opportunities a DayUsing our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.May 11, 2023 | americanbankingnews.comPrivia Health Group, Inc. (NASDAQ:PRVA) Major Shareholder Advisors L.L.C. Mbd Sells 24,819,473 Shares of StockMay 11, 2023 | americanbankingnews.comParth Mehrotra Sells 117,301 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) StockMay 8, 2023 | msn.comCredit Suisse Reiterates Privia Health Group (PRVA) Outperform RecommendationMay 8, 2023 | markets.businessinsider.comCredit Suisse Sticks to Its Buy Rating for Privia Health Group (PRVA)May 8, 2023 | americanbankingnews.comThomas Bartrum Sells 15,000 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) StockMay 7, 2023 | americanbankingnews.comInsider Selling: Privia Health Group, Inc. (NASDAQ:PRVA) Director Sells $496,666.08 in StockMay 7, 2023 | americanbankingnews.comPrivia Health Group (NASDAQ:PRVA) Sees Strong Trading Volume After Analyst UpgradeMay 6, 2023 | seekingalpha.comPrivia Health Group, Inc. (PRVA) Q1 2023 Earnings Call TranscriptMay 6, 2023 | americanbankingnews.comPrivia Health Group (NASDAQ:PRVA) Price Target Raised to $40.00 at SVB SecuritiesMay 6, 2023 | markets.businessinsider.comRBC Capital Remains a Buy on Privia Health Group (PRVA)May 5, 2023 | americanbankingnews.comDavid Mountcastle Sells 1,720 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) StockMay 5, 2023 | americanbankingnews.comThomas Bartrum Sells 1,801 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) StockMay 5, 2023 | barrons.comPrivia Health Announces Upsized Pricing of Secondary Offering of $936 Million of Common StockMay 4, 2023 | msn.comPrivia Health Group down 12% on pricing $689M secondary offeringMay 4, 2023 | finanznachrichten.dePrivia Health Group, Inc.: Privia Health Reports First Quarter 2023 Financial ResultsMay 4, 2023 | finance.yahoo.comPrivia Health Reports First Quarter 2023 Financial ResultsMay 4, 2023 | finance.yahoo.comPrivia Health Announces Pricing of Secondary Offering of $689 Million of Common StockMay 4, 2023 | finance.yahoo.comPrivia Health Announces Upsized Pricing of Secondary Offering of $936 Million of Common StockSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive PRVA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Privia Health Group and its competitors with MarketBeat's FREE daily newsletter. Email Address PRVA Company Calendar Last Earnings2/28/2023Today5/28/2023Next Earnings (Estimated)8/10/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Health services Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:PRVA CUSIPN/A CIK1759655 Webwww.priviahealth.com Phone571-366-8850FaxN/AEmployees810Year FoundedN/APrice Target and Rating Average Stock Price Forecast$39.19 High Stock Price Forecast$51.00 Low Stock Price Forecast$28.00 Forecasted Upside/Downside+60.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage13 Analysts Profitability EPS (Most Recent Fiscal Year)$0.11 Trailing P/E Ratio222.55 Forward P/E Ratio106.43 P/E Growth3.03Net Income$-8,590,000.00 Net Margins1.14% Pretax Margin0.12% Return on Equity3.20% Return on Assets2.02% Debt Debt-to-Equity RatioN/A Current Ratio1.90 Quick Ratio1.90 Sales & Book Value Annual Sales$1.36 billion Price / Sales2.09 Cash FlowN/A Price / Cash FlowN/A Book Value$4.81 per share Price / Book5.09Miscellaneous Outstanding Shares115,660,000Free Float49,041,000Market Cap$2.83 billion OptionableNot Optionable Beta0.77 Key ExecutivesMr. Matthew Shawn Morris (Age 58)CEO & Director Comp: $1.46MMr. Parth Mehrotra (Age 43)Pres & COO Comp: $1.21MMr. Thomas Bartrum (Age 55)Exec. VP & Gen. Counsel Comp: $536.6kMr. David Mountcastle CPA (Age 51)MBA, Exec. VP, CFO & Principal Accounting Officer Mr. Chris VoigtExec. VP & Chief Technology OfficerMr. Robert P. BorchertSr. VP of Investor Relations & Corp. CommunicationsMs. Dana Fields CPASr. VP of Internal Audit & Chief Compliance OfficerMs. Jenny HardingSr. VP of People OperationsMr. Jay StevensSr. VP & Chief Growth OfficerDr. Jim Sams M.D.CEO of Privia Medical Group - Georgia & Physician Exec. of Privia Medical Group - TennesseeMore ExecutivesKey CompetitorsLifeStance Health GroupNASDAQ:LFSTU.S. Physical TherapyNYSE:USPHP3 Health PartnersNASDAQ:PIIIDocGoNASDAQ:DCGOOak Street HealthNYSE:OSHView All CompetitorsInsiders & InstitutionsRoyce & Associates LPBought 20,000 shares on 5/23/2023Ownership: 0.084%JPMorgan Chase & Co.Bought 17,973 shares on 5/18/2023Ownership: 0.130%New York State Common Retirement FundSold 6,575 shares on 5/18/2023Ownership: 0.021%Silvercrest Asset Management Group LLCSold 5,038 shares on 5/16/2023Ownership: 0.477%Colony Group LLCSold 1,276 shares on 5/16/2023Ownership: 0.060%View All Insider TransactionsView All Institutional Transactions PRVA Stock - Frequently Asked Questions Should I buy or sell Privia Health Group stock right now? 13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Privia Health Group in the last year. There are currently 13 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" PRVA shares. View PRVA analyst ratings or view top-rated stocks. What is Privia Health Group's stock price forecast for 2023? 13 Wall Street research analysts have issued 1-year price objectives for Privia Health Group's shares. Their PRVA share price forecasts range from $28.00 to $51.00. On average, they predict the company's share price to reach $39.19 in the next year. This suggests a possible upside of 60.1% from the stock's current price. View analysts price targets for PRVA or view top-rated stocks among Wall Street analysts. How have PRVA shares performed in 2023? Privia Health Group's stock was trading at $22.71 on January 1st, 2023. Since then, PRVA stock has increased by 7.8% and is now trading at $24.48. View the best growth stocks for 2023 here. Are investors shorting Privia Health Group? Privia Health Group saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 5,740,000 shares, an increase of 189.9% from the April 30th total of 1,980,000 shares. Based on an average daily volume of 1,180,000 shares, the short-interest ratio is currently 4.9 days. Currently, 5.4% of the company's shares are short sold. View Privia Health Group's Short Interest. When is Privia Health Group's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 10th 2023. View our PRVA earnings forecast. How were Privia Health Group's earnings last quarter? Privia Health Group, Inc. (NASDAQ:PRVA) issued its earnings results on Tuesday, February, 28th. The company reported $0.14 earnings per share for the quarter, topping the consensus estimate of ($0.03) by $0.17. The business had revenue of $364.42 million for the quarter, compared to the consensus estimate of $337.16 million. Privia Health Group had a trailing twelve-month return on equity of 3.20% and a net margin of 1.14%. What ETFs hold Privia Health Group's stock? ETFs with the largest weight of Privia Health Group (NASDAQ:PRVA) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS), ROBO Global Healthcare Technology and Innovation ETF (HTEC), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), Franklin Genomic Advancements ETF (HELX), First Trust Mid Cap Growth AlphaDEX Fund (FNY), Renaissance IPO ETF (IPO), iShares U.S. Healthcare Providers ETF (IHF) and Principal U.S. Small-Cap Multi-Factor ETF (PSC). What guidance has Privia Health Group issued on next quarter's earnings? Privia Health Group issued an update on its FY 2023 earnings guidance on Wednesday, April, 19th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.55 billion-$1.65 billion, compared to the consensus revenue estimate of $2.79 billion. When did Privia Health Group IPO? (PRVA) raised $351 million in an initial public offering on Thursday, April 29th 2021. The company issued 19,500,000 shares at a price of $17.00-$19.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse, Piper Sandler and William Blair acted as the underwriters for the IPO and Canaccord Genuity, Truist Securities, R. Seelaus & Co. and Siebert Williams Shank were co-managers. What is Privia Health Group's stock symbol? Privia Health Group trades on the NASDAQ under the ticker symbol "PRVA." Who are Privia Health Group's major shareholders? Privia Health Group's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (3.99%), Bank of New York Mellon Corp (3.09%), Principal Financial Group Inc. (1.99%), Riverbridge Partners LLC (1.96%), FMR LLC (1.47%) and Franklin Resources Inc. (1.09%). Insiders that own company stock include Advisors LLC Mbd, David Mountcastle, Jeffrey B Butler, Jeffrey Daniel Bernstein, Matthew Shawn Morris, Pamplona Capital Partners Iii,, Parth Mehrotra, Thomas Bartrum and William M Sullivan. View institutional ownership trends. How do I buy shares of Privia Health Group? Shares of PRVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Privia Health Group's stock price today? One share of PRVA stock can currently be purchased for approximately $24.48. How much money does Privia Health Group make? Privia Health Group (NASDAQ:PRVA) has a market capitalization of $2.83 billion and generates $1.36 billion in revenue each year. The company earns $-8,590,000.00 in net income (profit) each year or $0.11 on an earnings per share basis. How many employees does Privia Health Group have? The company employs 810 workers across the globe. How can I contact Privia Health Group? The official website for the company is www.priviahealth.com. The company can be reached via phone at 571-366-8850 or via email at ir@priviahealth.com. This page (NASDAQ:PRVA) was last updated on 5/28/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Privia Health Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.